Fig. 4From: Meeting Report: Vaccine Stability Considerations to Enable Rapid Development and DeploymentKinetics of Impurity Formation under Accelerated Conditions. Excerpt from Lennard, A., Taking Stability Off the Critical Path of Vaccine Product Development, AAPS Vaccine Stability Workshop, March 24-25, 2021Back to article page